KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Charles River Laboratories International (CRL) Revenue: 2009-2024

Historic Revenue for Charles River Laboratories International (CRL) over the last 16 years, with Dec 2024 value amounting to $4.0 billion.

  • Charles River Laboratories International's Revenue fell 0.49% to $1.0 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $4.0 billion, marking a year-over-year decrease of 0.92%. This contributed to the annual value of $4.0 billion for FY2024, which is 1.92% down from last year.
  • According to the latest figures from FY2024, Charles River Laboratories International's Revenue is $4.0 billion, which was down 1.92% from $4.1 billion recorded in FY2023.
  • Charles River Laboratories International's 5-year Revenue high stood at $4.1 billion for FY2023, and its period low was $2.9 billion during FY2020.
  • In the last 3 years, Charles River Laboratories International's Revenue had a median value of $4.0 billion in 2024 and averaged $4.1 billion.
  • In the last 5 years, Charles River Laboratories International's Revenue grew by 21.08% in 2021 and then dropped by 1.92% in 2024.
  • Over the past 5 years, Charles River Laboratories International's Revenue (Yearly) stood at $2.9 billion in 2020, then climbed by 21.08% to $3.5 billion in 2021, then grew by 12.31% to $4.0 billion in 2022, then grew by 3.86% to $4.1 billion in 2023, then decreased by 1.92% to $4.0 billion in 2024.